Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 15

1.

Immune activation and neuroinflammation in alcohol use and HIV infection: evidence for shared mechanisms.

Monnig MA.

Am J Drug Alcohol Abuse. 2017 Jan;43(1):7-23. doi: 10.1080/00952990.2016.1211667. Epub 2016 Aug 17.

PMID:
27532935
2.

A Bayesian nonparametric approach to marginal structural models for point treatments and a continuous or survival outcome.

Roy J, Lum KJ, Daniels MJ.

Biostatistics. 2017 Jan;18(1):32-47. doi: 10.1093/biostatistics/kxw029. Epub 2016 Jun 26.

PMID:
27345532
3.

HIV-associated neurocognitive disorders: the relationship of HIV infection with physical and social comorbidities.

Tedaldi EM, Minniti NL, Fischer T.

Biomed Res Int. 2015;2015:641913. doi: 10.1155/2015/641913. Epub 2015 Mar 1. Review.

5.

Attitudes and Training Needs of New England HIV Care and Addiction Treatment Providers: Opportunities for Better Integration of HIV and Alcohol Treatment Services.

Montague BT, Kahler CW, Colby SM, McHugh RK, Squires D, Fitzgerald B, Operario D, Gallagher D, Monti PM, Mayer KH.

Addict Disord Their Treat. 2015 Mar;14(1):16-28.

6.

Select neurocognitive impairment in HIV-infected women: associations with HIV viral load, hepatitis C virus, and depression, but not leukocyte telomere length.

Giesbrecht CJ, Thornton AE, Hall-Patch C, Maan EJ, Côté HC, Money DM, Murray M, Pick N.

PLoS One. 2014 Mar 4;9(3):e89556. doi: 10.1371/journal.pone.0089556. eCollection 2014.

7.
8.

Human immunodeficiency virus infection heightens concurrent risk of functional dependence in persons with long-term methamphetamine use.

Blackstone K, Iudicello JE, Morgan EE, Weber E, Moore DJ, Franklin DR, Ellis RJ, Grant I, Woods SP; Translational Methamphetamine AIDS Research Center Group..

J Addict Med. 2013 Jul-Aug;7(4):255-63. doi: 10.1097/ADM.0b013e318293653d.

9.

Assessment, diagnosis, and treatment of HIV-associated neurocognitive disorder: a consensus report of the mind exchange program.

Mind Exchange Working Group..

Clin Infect Dis. 2013 Apr;56(7):1004-17. doi: 10.1093/cid/cis975. Epub 2012 Nov 21.

10.

Successful aging and the epidemiology of HIV.

Vance DE, McGuinness T, Musgrove K, Orel NA, Fazeli PL.

Clin Interv Aging. 2011;6:181-92. doi: 10.2147/CIA.S14726. Epub 2011 Jun 28. Review.

11.

Neurocognitive impact of substance use in HIV infection.

Byrd DA, Fellows RP, Morgello S, Franklin D, Heaton RK, Deutsch R, Atkinson JH, Clifford DB, Collier AC, Marra CM, Gelman B, McCutchan JA, Duarte NA, Simpson DM, McArthur J, Grant I; CHARTER Group..

J Acquir Immune Defic Syndr. 2011 Oct 1;58(2):154-62. doi: 10.1097/QAI.0b013e318229ba41.

12.

Perceptions of alcohol risk among individuals living with HIV.

Shacham E, Hoffer L, Overton ET.

AIDS Care. 2011 Jan;23(1):107-12. doi: 10.1080/09540121.2010.498862.

13.

Neuropsychological Dysfunction among HIV Infected Drug Abusers.

Durvasula RS, Hinkin CH.

Am J Infect Dis. 2006;2(2):67-73.

14.

Drug abuse and hepatitis C infection as comorbid features of HIV associated neurocognitive disorder: neurocognitive and neuroimaging features.

Martin-Thormeyer EM, Paul RH.

Neuropsychol Rev. 2009 Jun;19(2):215-31. doi: 10.1007/s11065-009-9101-6. Epub 2009 May 27. Review.

15.

HIV-1 neuropathogenesis: glial mechanisms revealed through substance abuse.

Hauser KF, El-Hage N, Stiene-Martin A, Maragos WF, Nath A, Persidsky Y, Volsky DJ, Knapp PE.

J Neurochem. 2007 Feb;100(3):567-86. Epub 2006 Dec 1. Review.

Supplemental Content

Support Center